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1. Introduction  
Human embryonic stem cells (hESCs) have two properties that distinguish them from other 
cell types: self-renewal, the ability to propagate indefinitely in culture, and pluripotency, the 
ability to differentiate into any type of specialized cells found in the human body. These 
properties provide the foundation for the development of hESC-derived cell-based 
therapeutics, where specific cell types derived by differentiation of hESCs become a 
therapeutic agent that cures the disease or restores the function of damaged organs or tissue. 
To make this a reality, several technologies must be developed to provide an unlimited and 
consistent supply of hESC-derived cells for clinical use. These include robust and scalable 
methods for production of undifferentiated hESCs, differentiation of the hESCs into 
desirable cell types, recovery, purification, storage and transportation of the derived cells to 
the location of use, and methods and techniques for delivery of the therapeutic cells to a 
human body to provide health benefits. 
Since the derivation of the first hESC lines by Thomson, J. et al. (Thomson, 1998) and 
Reubinoff, B. et al. (Reubinoff et al., 2000), hundreds of new lines have been established and 
propagated under various cell culture conditions. Historically, hESCs were maintained in 
complex culture systems under poorly defined conditions comprising mouse or human 
feeder cell layers and medium containing fetal bovine serum (FBS) or serum replacement to 
provide an extracellular matrix (ECM)-rich environment for cell adhesion, as well as soluble 
growth factors for self-renewal. It is highly desirable that the cell culture systems utilized for 
therapeutic cells, including cell culture surfaces and the media, are well defined (all 
components are known and characterized and their abundance is controlled) and of non-
animal origin or xeno-free (do not contain biological materials of a non-human nature). 
Establishment of the first human embryonic stem cell line (Thomson, 1998) was 
accomplished by extending to hESCs a cell culture system developed for culturing mouse 
embryonic stem cells that is based on inactivated mouse embryonic fibroblasts (MEF) as a 
feeder layer. Soon after the first reports on isolation of human pluripotent cells came 
realization that feeder-free cell culture is essential for production of cells for transplantation 
(Donovan & Gearhart, 2001; Pera et al., 2000); (Pedersen, 2002). Back in 2000 this looked like 
a challenge that would require a very long time to overcome, as 19 prior years of using 
MEFs to support stem cell culture of non-human cells did not result in significant 
understanding of what exactly MEFs provide for stem cells. To make matters worse, there 
was experimental evidence showing that neither MEF conditioned medium nor ECM 
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secreted by MEFs alone was sufficient to produce the same outcomes (Thomson, 1998). Ten 
years later, a fully synthetic cell culture surface (Corning® SynthemaxTM Surface), which 
allows xeno- and serum-free culture and differentiation of therapeutic quality stem cells 
under chemically defined conditions, became commercially available to address this 
problem.  
In this chapter, we will review the evolution of hESC culture conditions from complex un-
defined feeder layer surfaces and FBS-containing medium used initially to derive and 
maintain hESC in culture, to fully defined, xeno-free culture systems described by multiple 
independent studies in the past few years.  The focus of our review will be a development of 
an element of the cell culture system, a fully defined, xeno-free cell culture surface, and the 
benefits of a fully synthetic cell culture surface for propagation and differentiation of human 
embryonic stem cells.  
Authors of this chapter are Corning Incorporated employees and have financial conflicts of 
interest. 
2. Importance and significance of a fully defined cell culture system  
The envisioned applications of hESCs, such as cell therapy and drug discovery, require 
growth and differentiation of hESCs on a large scale. Despite numerous ongoing clinical 
trials involving adult and human embryonic stem cells as a source of cells for a variety of 
therapies, there are fundamental challenges in large scale manufacture of hESCs that need to 
be addressed. These challenges include measurement metrics defining purity and the 
quality of the produced cells for a particular therapy application, complexity and variability 
of cell culture environment for different stem cells and their derivatives, and a need for 
automation of hESCs culture to bring the required consistency and repeatability into the cell 
therapy process (Thomas & Williams, 2009).   
A recent review of cell culture procedures for hESCs (Fernandes et al., 2010) reports that in 
the vast majority (>80%) of cell culture studies published in 2009, hESCs were grown either 
on MEFs and cell lines derived from MEFs, or human feeder cells. In less than 18% of the 
studies the cells were cultured on other surfaces, ~16.5% of which used MatrigelTM, an 
extracellular matrix isolated from Engelbreth-Holm-Swarm (EHS) mouse sarcoma (Becton 
Dickinson, Bedford, MA).  
In the US, regulation of production and marketing of stem cell based therapies falls under 
FDA (Food and Drug Administration) jurisdiction. FDA repeatedly expressed concerns in 
regards to the potential use of stem-cell products derived from hESC that were isolated and 
cultured on MEFs (Halme & Kessler, 2006) and indicated the necessity of testing these cells 
for adventitious agents to meet FDA xenotransplantation guidelines. Another source of 
animal-derived biological material is non-human serum, which is frequently used in cell 
culture. FDA views fetal bovine serum (FBS) as a possible source of the prion that causes 
bovine spongiform encephalopathy and requires that FBS is produced in a country certified 
to be free of this disease (Kirschstein & Skirboll, 2001).  
Cell culture surfaces, as a part of the cell culture system, should meet FDA guidelines and 
address hESCs process scalability issues. The desirable attributes for hESC cell culture 
surfaces for an animal product-free cell culture are an absence of animal derived materials 
and ideally even human derived materials (as those too may be subject to batch-to-batch 
variability and contamination with human pathogens), and compatibility with a defined, 
serum-free media. Other typical cell culture surface attributes include absence of 
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extractables, particulates, and other contaminants, compatibility with conventional 
sterilization techniques (typically gamma irradiation), stability at room temperature, 
similarity to common tissue culture treated (TCT) polystyrene and other cell culture 
surfaces, and, ideally, the surface needs to be ready for use, rather than require further 
preparation and manipulation.  
3. Progress in hESC culture conditions 
The first significant improvement in hESC culture conditions was reported by Geron 
Corporation in 2001 (Xu et al., 2001). When Matrigel and gelatine were tested as surfaces for 
hESC lines H1, H7, H9 and H14 using MEF conditioned medium, all cells attached to 
Matrigel, formed tight colonies separated by differentiated cells, and propagated. In 
contrast, the cells on gelatine showed poor survival and appeared differentiated after one 
passage. Since the major constituents of Matrigel are laminin, collagen IV, heparan sulfate 
proteoglycans, and entactin/nidogen (Kleinman et al., 1982, Kleinman, 1986 #244), the 
authors then explored individual ECM components of Matrigel and observed great 
similarity between Matrigel and laminin cultured cells. 
Further investigation of hESC culture using media conditioned with cells other than MEFs 
(STO, an immortal mouse embryonic fibroblast; NHG190, a transfected mouse embryonic 
cell line; BJ5ta, an immortalized human foreskin fibroblast cell line; an immortalized 
human retinal epithelial cell line) revealed that only Matrigel (or laminin) and MEF 
conditioned medium maintain long-term propagation of undifferentiated hESCs, as cells 
under other conditions differentiated within 1 to 7 passages. There was no difference 
found in integrin expression profiles between cells cultured on MEFs, Matrigel, or 
laminin, and cells under all three of these cell culture conditions expressed 6 and 1 
integrins consistent with integrin mediated hESC attachment to laminin. The cultured 
cells were positive for Tra-1-60 and Tra-1-81, negative for SSEA-1, and formed teratomas 
with various differentiated cells in immunodefficient mice. These data demonstrated the 
capability of a MEF-free surface to support proliferation of hESCs in an undifferentiated 
state.  
While Matrigel was a significant improvement over MEFs, its mouse origin and undefined 
and variable nature makes it highly undesirable as a substrate for therapeutic hESC scale 
up. It was also found that current hESC lines derived on MEF and cultured on Matrigel in 
the presence of animal serum have nonhuman sialic acid Neu5Gc, a potential immunogen, 
incorporated into their cell membranes (Martin et al., 2005). Exposure of the cells to human 
sera with antibodies specific for Neu5Gc resulted in binding of immunoglobulin and 
complement deposition, which would lead to cell killing in vivo, thus significantly reducing 
the efficacy of cell therapy. After reviewing several approaches, Martin et al. concluded that 
it is easier and safer to start over and derive hESC lines without exposing cells to animal 
products containing Neu5Gc.  
The elimination of animal derived products from hESC culture requires a xeno-free cell 
culture surface and medium. The interdependence of the cell culture surface and medium in 
providing optimal conditions for cell culture performance made progress in this field 
iterative. Short term solutions involved human feeder cells (Genbacev et al., 2005), (Choo et 
al., 2004), and serum replacement or serum-free medium (Amit et al., 2000).  
The next significant milestone in development of hECS culture was achieved in 2005 (Xu et 
al., 2005), when Geron demonstrated proliferation of H7 and H9 hESCs in serum-free 
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medium on Matrigel. Geron evaluated 15 growth factors and their combinations at various 
doses in a medium containing 80% Knockout–Dulbecco’s modified Eagle’s medium, 20% 
KnockoutTM serum replacement (Invitrogen, Carlsbad, CA), 1 mM L-glutamine, 0.1 mM ┚-
mercaptoethanol, 1% nonessential amino acids. Although the exact composition of 
KnockoutTM formulation is a commercial secret, the product is a more-defined growth 
supplement (Price et al., 1998) that reduces the spontaneous differentiation of ESCs. Basic 
fibroblast growth factor (bFGF) was found to support growth of hESCs without conditioned 
medium. 
This was followed up by a study conducted at Prof. J. A. Thomson’s lab that disclosed a 
complete composition of serum- and xeno-free medium, TeSR1, for hESC culture (Ludwig et 
al., 2006). The medium is based on DMEM/F12 medium supplemented with bFGF, TGF-1, 
LiCl, -aminiobutyric acid, and pipecolic acid. It contains only six polypeptides (Table 1) and 
none of them is of animal origin. Ludwig et al. also screened a variety of human ECM proteins 
individually and in combination to establish that a substrate coated with a mixture of collagen 
IV, fibronectin, laminin, and vitronectin can support growth of H1 and H9 hESC lines for at 
least 7 months. The stem cells cultured under these conditions did not test positive for the 
presence of nonhuman sialic acid. Despite these advances, the importance of further 
optimization of the cell culture surface was recognized, as the purified human matrix 
components are expensive and could potentially be contaminated with human pathogens.  
When compared to different human ECM proteins, as well as human and animal sera 
matrices (Hakala et al., 2009), Matrigel was found to be a superior hESC culture surface. The 
comparison was performed using conventional and modified hESC culture media that 
included human foreskin fibroblast-conditioned culture medium, chemically defined 
mTeSR1 medium and its xeno-free counterpart, TeSR1 medium. Judging by the maximum 
passage number attainable, hESC morphology, and expression of stem cell markers, Hakala 
concluded that a xeno-free, fully defined, and reproducible feeder cell–free hESC culture 
method still remained to be developed.  
 
Polypeptide Conc. mM 
bFGF 5.77 10-6 
TGF 1 2.35 10-8 
Human Insulin 3.92 10-3 
Human Holo-Transferrin 1.37 10-4 
Human Serum Albumin 1.95 10-1 
Glutathione  6.38 10-3 
Table 1. Polypeptides in TeSR1, (Ludwig et al., 2006) 
4. Synthetic surfaces for hESCs 
Typically cells are cultured on a polystyrene surface that is rendered hydrophilic (e.g. TCT 
and Corning CellBIND culture ware) by various plasma treatments. It is recognized that 
cell attachment occurs through interactions between integrins, cell adhesion receptors, and 
extracellular matrix proteins. To enable cell attachment to a surface, ECM proteins need to 
be immobilized on that surface first.  
The proteins adsorb onto a surface from the culture medium, in which case serum 
supplement is a source of ECM proteins. However, when hESCs are cultured on a TCT 
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surface in serum supplemented medium (80% Dulbecco modified Eagle’s medium 
supplemented with 20% fetal bovine serum), they undergo differentiation within a passage 
or two (Thomson, 1998). Alternatively, the ECM could be secreted by the cultured cells. 
Unlike other cell types, hESCs do not secrete a sufficient amount of ECM to sustain 
themselves in an undifferentiated state (Braam et al., 2008). Therefore, development of a 
synthetic surface for hESC culture under serum free conditions is not a trivial task (Couture, 
2010), (Elefanty & Stanley, 2010).  
The approaches to develop a solution to the problem described above can be grouped into 
three categories. First is to design a surface that facilitates ECM protein adsorption. The second 
is to identify a specific extracellular matrix protein that could be manufactured at a significant 
scale and coated onto conventional cell culture surfaces. The third approach entails 
development of a biomimetic surface that mimics the function of extracellular matrix proteins. 
4.1 Polymer surfaces facilitating ECM protein adsorption. 
Attempts to develop a surface for hESC culture using conventional polymers involved 
investigation of improved processing methods for polystyrene (Mahlstedt et al.). When 
TCPS (tissue culture polystyrene) was etched using radio frequency oxygen plasma for 5 
min at pressures below 20 mT, HUES7 and NOTT1 hESC lines attached and proliferated on 
the surface for at least 10-14 passages in MEF conditioned medium showing doubling times 
similar to those for cells cultured on Matrigel and expressing hESC pluripotency markers. 
BD PrimariaTM and Corning CellBIND surfaces were tested in a similar experiment as 
controls and also demonstrated the ability to support hESC culture to some extent. Quartz 
crystal microbalance analysis showed an increase in the amount of adsorbed proteins from 
conditioned medium onto the plasma etched surface, which was related to the improved cell 
culture performance. The proposed underlying mechanism is an increased hydrophilicity of 
the surface that enables replacement of small albumin, which is the first protein to adsorb 
onto the surface due to its abundance in serum, over time with less abundant, higher 
molecular weight, cell adhesive proteins. Attempts to culture hESCs on this surface using 
mTeSR1 or StemPro® hESC defined media were unsuccessful, as these media do not contain 
cell adhesion ECM proteins. 
Similar material properties were achieved through organic synthesis. Villa-Diaz (Villa-Diaz 
et al., 2010) identified a polymer, poly[2-(methacryloyloxy)ethyl dimethyl-(3-
sulfopropyl)ammonium hydroxide, which, when coated on polystyrene, supported the 
undifferentiated proliferation of BG01 and H9 hESC lines for over 25 passages in MEF-
conditioned medium. The surface did not support hESC culture in mTeSR1 medium, while 
mixed result were observed in StemPro medium, the composition of which is not disclosed. 
A more recent study (Brafman et al., 2010) described screening of 90 polymers for their 
ability to support hESC culture. Brafman identified only one polymer, poly(methyl vinyl 
ether-alt-maleic anhydride) (PMVE-alt-MA), that HUES1 and HUES9 cells attached to and 
proliferated for five passages in StemPro medium. The expression levels of endogenous 
ECM proteins and integrins in hESCs grown on PMVE-alt-MA were found to be 
significantly higher compared to hESCs grown on Matrigel, suggesting that the cells were 
generating ECM proteins required for their attachment to the surface.  
4.2 Extracellular matrix protein coatings 
Multiple publications demonstrated that Matrigel could be replaced, under certain 
conditions, with a mixture of collagen, fibronectin, laminin, and vitronectin (Ludwig et al., 
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2006), or even individual ECM proteins including laminin, fibronectin, or vitronectin (Table 
2). As evidenced by the data, conditioned medium can support hESC proliferation in an 
undifferentiated state on most common ECM proteins. However, transition to defined 
media such as mTeSR1, TeSR1, X-VIVO™ 10 seems to restrict the choice to laminin or 
vitronectin. 
Laminin is a major constituent of Matrigel, and it was the first pure ECM protein identified 
to support hESC attachment and proliferation of the hESCs (Xu et al., 2001). Fairly recently, 
a detailed study by Braam et al. demonstrated the ability of vitronectin to support hESC 
culture in mTeSR1 medium and investigated the underlying mechanism (Braam et al., 2008). 
E-Cadherin, a cell-cell adhesion glycoprotein, also was shown to enable attachment and 
propagation of H9 cells in mTeSR1 medium (Nagaoka et al., 2010).  
 
Protein Cell line Medium Passages Reference 
Laminin 
Collagen 
Fibronectin 
H1,H9 
H1 
H1 
MEF conditioned 
6-7 
6 
6 
(Xu et al., 2001), 
Laminin H1 X-VIVO 10 + GF 40 (Li et al., 2005) 
Laminin 
KhES-1, 
KhES-2, hES-3 
MEF conditioned 10 (Miyazaki et al., 2008) 
Laminin 
HS420, HS207, 
HS401, H1, H9 
Variants of TeSR1 
and mTeSR1 
5-20 (Rodin et al., 2010) 
Fibronectin H9, BG01 HESCO 8 (Lu et al., 2006) 
Fibronectin I-3, I-6, H9 Knockout SR >50 (Amit et al., 2004) 
Collagen I H1, H9 SDEC conditioned 5 (Jones et al. 2010) 
Collagen I 
HUES-1 
Shef 1 
hESF9 
21 
15 
(Furue et al., 2008) 
Vitronectin 
MEL1, MEL2, 
hES1 
StemPro >10 (Prowse et al., 2010) 
Vitronectin 
HUES1, HES2, 
HESC-NL3 
mTeSR1 12 (Braam et al., 2008) 
Vitronectin H9 mTeSR1 10 (Rowland et al., 2010) 
Vitronectin HES-3, H1 mTeSR1 >30 (Yap et al., 2011) 
Vitronectin CHA6, H9 mTeSR1 >30 (Yoon et al., 2010) 
E-Cadherin H9 mTeSR1 37 (Nagaoka et al., 2010) 
Table 2. ECM surfaces for hESC culture. 
Miyazaki et al., (Miyazaki et al., 2008) investigated attachment of  three hESC lines (KhES-1, 
KhES-2, and KhES-3) to various recombinant laminins (511, 411, 332, 211, and 111) in MEF 
conditioned medium and observed a significant discrepancy in cell attachment to these 
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laminins with laminin 332 showing the best performance across these cell lines. Others 
reported recombinant laminin-511 to be a good substrate for HS420, HS207, and HS401 cell 
lines (Rodin et al., 2010).  
Although extracellular matrix protein coatings are frequently used for hESC culture in 
research labs, application of these coatings to hESC scale up is not straightforward. 
Recombinant proteins are fairly expensive to produce and purify. They are prone to batch-
to-batch variabity, need to be coated onto a surface under aseptic conditions, and they can 
degrade or denature upon dehydration. Published protocols indicate that coatings of 
purified proteins require optimization (Yap et al., 2011); for example, a defined thickness 
threshold needs to be achieved to enable hESCs attachment and proliferation rates similar to 
those observed on Matrigel coatings. Formation of such a coating requires a significant 
period of time (hours) under aseptic conditions. Utilization of the protein for the coating is 
very inefficient, as >50% of it remains in the solution. All this makes purified protein cell 
culture surfaces expensive and limits their scalability.  
4.3 Biomimetic surfaces for stem cells 
The interest in synthetic biomimetic surfaces was initiated by a discovery of the RGD 
(arginine-glycine-aspartic acid) peptide sequence present in most ECM proteins. When 
coupled to a surface, the RGD sequence promotes cell attachment (Pierschbacher & 
Ruoslahti, 1984). A large variety of polymer materials incorporating RGD peptides have 
been designed and studied (Hersel et al., 2003). 
Cells attach to the ECM through integrins, cell adhesion receptors (Humphries et al., 2006), 
(Hynes, 2002). Integrins support a broad spectrum of cellular functions including 
proliferation and differentiation, and can bind to such ECMs as collagen, fibronectin, 
laminin, vitronectin, and N-linked glycoproteins, (e.g. osteopontin and bone sialoprotein). 
They can also interact with other cells through vascular- or intracellular- cell adhesion 
molecules (VCAM and ICAM). The integrins are heterodimeric molecules consisting of  
and  subunits. There are twenty four known  combinations, which can be divided into 
several subfamilies based on evolutionary relationships. The orthologs of human integrins 
recognizing the RGD amino acid sequence and laminins can be traced back to primitive 
organisms, while other integrins must have evolved with increasing organism complexity.  
From such a perspective, it is not surprising that hESCs primarily express integrins 
recognising the RGD sequence and laminin (Braam et al., 2008), (Meng et al., 2010), 
(Rowland et al., 2010), (Prowse et al., 2011). Braam et al., evaluated integrin expression in 
three hESC lines (HES2, HUES1, and HESCNL3) using fluorescence-activated cell sorting 
analysis. While integrin chains 1, 4, 10, and 3 and integrins 91 and V6 were either 
not detected or detected at very low levels, cells expressed integrin chains 2, 3, 5, 6, 
11, 1 and integrin V5. This leaves the following combinations of integrin chains to 
enable cell attachment: 21, 31, 51, 61, 111, V5, and V1. These 
combinations, designated in Figure 1 as small orange circles, comprise cell surface receptors 
for all major ECM components.  
It was also found, as discussed in the previous section, that attachment through either 
laminin or RGD binding integrins (Li et al., 2005), (Rodin et al., 2010), (Wong et al., 2010), 
(Braam et al., 2008), (Rowland et al., 2010), (Yoon et al., 2010), (Yap et al., 2011) is sufficient 
to support undifferentiated proliferation of hECS in serum-free, chemically defined 
medium.  
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Fig. 1. Mammalian intergrins and their ligands (Humphries et al., 2006) 
For these reasons, surfaces with immobilized laminin and RGD peptides were studied as 
synthetic surfaces for hESC proliferation (Li et al., 2006), (Derda et al., 2007), (Melkoumian et 
al., 2010) (Derda et al., 2010), (Klim et al., 2010). Li et al. was first to demonstrate that grafting 
the RGD containing peptide, Ac-KGGNGEPRGDTYRAY, from bone sialoprotein to 
acrylamide-acrylic acid copolymer can support short term attachment and proliferation of 
HSF-6 hESCs in MEF conditioned KSR-supplemented medium. The colonies of hESCs 
expressed Oct-4 and SSEA-4 markers of undifferentiated hESCs after five days in culture and 
maintained the same morphology as those cultured under the same conditions on Matrigel.  
Derda et al. extensively studied laminin-derived peptides (Derda et al., 2007) in an attempt 
to identify specific sequences supporting hESC attachment. Using a self-assembled 
monolayers technique, the authors discovered several peptides enabling attachment and 
short term proliferation (6 days) of hESCs, again though, in MEF conditioned medium. The 
most important finding, which facilitated further advancement in the field, was an 
observation that hESCs, in comparison to other cells, require relatively high surface peptide 
densities due to low expression levels of corresponding integrins.  
This suggests a hypothesis where a critical number of integrins on the cell surface are needed 
to be simultaneously engaged to enable optimal hESC adhesion. At low surface peptide 
density the probability of such engagement is reduced. We (Melkoumian et al., 2010) focused 
efforts on peptide-acrylate surfaces (PASs), as did others (Li et al., 2006), and pursued high 
peptide densities through optimization of acrylate polymer and peptide conjugation. The 
developed poly(hydroxyethyl methacrylate-co-carboxyethyl acrylate) coating provides a 
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significant amount of functional groups for peptide conjugation, while its swellable nature 
enhances presentation and accessibility of the conjugated peptide for integrin binding. 
Co-conjugating a small amount of fluorescently labelled peptide together with a cell binding 
peptide and comparing the fluorescence intensities to a calibration curve generated by 
drying down the same mixture of peptides onto the acrylate surface, we estimated that a 
BSP peptide (Table 3) density of 6-9 pmol/mm2 is sufficient to enable cell culture 
performance in X-VIVO 10 medium similar to Matrigel (Melkoumian et al., 2010), (Figure 2).  
An alternative approach in enabling hESC adhesion and proliferation was demonstrated by 
Kohlar, et al., (Kolhar et al., 2010), who employed cyclic RGD peptides to improve the 
strength of peptide – integrin binding to achieve a similar outcome. The reported peptide 
densities, 0.1–0.3 fmol/mm2, are significantly lower. Nevertheless, stronger integrin binding 
to cyclic peptide allows development of a sufficient number of peptide-integrin interactions 
to enable cell attachment and proliferation. 
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c)      d) 
Fig. 2. Conjugated peptide surface density assessment; a) Fluorescence scan of dried down 
peptides representing various peptide densities; b) Fluorescence of conjugated peptide 
mixture; c) BSP peptide concentration (mM)-dependent H7 cell number after 5 days in 
culture in X-VIVO™ 10 + 80 ng/ml bFGF + 0.5 ng/ml TGF1 medium on PAS in 6-well 
plate, conjugated with serial dilution of BSP peptide. Cell seeding density was 1 x 106 cells 
per well; d) Peptide density calibration curve; (Melkoumian et al., 2010), supplementary 
Figure 1A and Figure 1B. 
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When a series of RGD peptides (Table 3) from various ECM proteins (bone sialoprotein, 
vitronectin, and fibronectin) was conjugated to the acrylate coating and tested for their 
ability to support hESC culture, only BSP and VN peptides supported attachment and 
proliferation of H1 and H7 hESCs similar to Matrigel (Melkoumian et al., 2010). None of the 
fibronectin peptides provided adequate cell attachment. According to Humphries et al., BSP 
protein engages the same integrins, V5 and V3, as vitronectin suggesting the same 
integrin activation by both BSP and VN peptides, (see Figure 1). Braam et al. (Braam et al., 
2008) reported binding of hESCs to vitronectin through V5 integrin and showed it being 
sufficient for cell self-renewal under chemically defined conditions. Since V3 integrin was 
not detected in that study, it is highly likely that BSP and VN peptides enable hESC 
attachment through V5 integrin, as it is the only remaining choice for BSP peptide, 
(Figure 1). This interaction is fairly specific and that specificity is governed by RGD flanking 
sequences. 
Peptide based cell culture surfaces are not limited to integrin interactions, but can also be 
designed to take advantage of multiple attachment mechanisms. Recently Klim at el., (Klim 
et al., 2010) demonstrated self-assembled monolayer peptide biomimetic surfaces that 
included peptides binding to glycosaminoglycans. The cell culture surface presenting 
vitronectin peptide GKKQRFRHRNRKG was found to support attachment and proliferation 
of H9, H13, and H14 cells in mTeSR1 medium in the presence of ROCK inhibitor.  
 
Sequence Abbreviation Reference 
Ac-KGGNGEPRGDTYRAY BSP (Oldberg et al., 1988) 
Ac-KGGPQVTRGDVFTMP VN (Suzuki et al., 1985) 
GRGDSPK FN-1 (Pierschbacher & Ruoslahti, 1984) 
Ac-KGGAVTGRGDSPASS FN-2 (Pierschbacher & Ruoslahti, 1984) 
BSP, bone sialoprotein; VN, vitronectin; FN, fibronectin. 
Table 3. Peptide sequences conjugated to acrylate coatings; (Melkoumian et al., 2010) 
 
 
Fig. 3. Consistency of doubling time for H7 cells grown on Corning SynthemaxTM and 
MatrigelTM. 
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The fact that hESCs can be cultured under defined conditions on a variety of substrates, 
from complex ECM protein mixtures to single peptide surfaces, demonstrates the native 
ability of undifferentiated hESCs to propagate without the need for a very precise and 
complex signalling through adhesion receptors (Klim et al., 2010), (Ying et al., 2008). 
One of the desirable and anticipated advantages of synthetic surfaces is improved 
consistency and reproducibility of cell culture performance. Non-biological, small molecular 
weight compounds required for manufacture of synthetic surface can be consistently 
obtained in high quantity and purity and can be manipulated in a conventional industrial 
setting. When compared to proteins, short peptides can be easily manufactured via chemical 
synthesis. Purification and quality assurance are dramatically less complex for peptides. 
Short peptides do not denature and exhibit higher stability towards chemical and physical 
agents, thus, overall providing a scalable manufacturing platform for hESC cell culture 
surfaces, enabling cell therapy applications. This will translate into industrial processes 
resulting in consistent cell culture surface, as it did for tissue culture treated polystyrene 
surfaces. We observed a clear improvement in cell culture consistency at the early stages of 
surface development (Figure 3).  
 
Cell 
Line 
Culture 
Medium 
Surface 
Doubling 
Time (h) 
%Oct-4 + 
Cells 
%Tra1-60 
+ cells 
%SSEA-4 
+ cells 
Passages 
H7 
X-VIVO 10 
Synthemax 41 ± 5 92 ± 4 85 100 
21 
Matrigel 50 ± 12 92 ± 3 96 100 
mTeSR1 
Synthemax 55 ± 21 90 ± 4 66 - 
11 
Matrigel 69 ± 26 83 ± 8 56 - 
StemPro 
Synthemax 31 ± 6 96 ± 0 - - 
5 
Geltrex 31 ± 5 97 ± 0 - - 
NutriStem™ 
Synthemax 32 ± 9 92 ± 3 - - 
5 
Matrigel 35 ± 4 92 ± 6 - - 
H1 X-VIVO 10 
Synthemax 46 ± 8 82 ± 5 78 ± 4 91 
14 
Matrigel 53 ± 16 80 ± 8 83 ± 6 84 
H9 mTeSR1 
Synthemax 43 ± 3 93 ± 5 73 ± 4 - 
5 
Matrigel 44 ± 6 95 ± 4 76 ± 2 - 
BG01v mTeSR1 
Synthemax 40 ± 6 86 ± 6 - - 
11 
Matrigel 44 ± 6 89 ± 5 - - 
Table 4. hESC long-term expansion on Synthemax™ in defined media: X-VIVO™ 10 (Lonza, 
+ 80ng/ml bFGF + 0.5ng/ml TGFb1); mTeSR1 (Stem Cell Technologies); NutriStem™ 
(StemGent); StemPro hESC SFM (Invitrogen).  
Since the publication in Nature Biotechnology (Melkoumian et al., 2010) gamma sterilization 
methods were developed for the peptide acrylate surface and the surface was 
commercialized under the Corning® SynthemaxTM Surface trade name. It is being offered in 
two grades (therapeutic and research) in a number of formats including 6-well plates, T-75 
and T-225 flasks. The utility of the surface has been demonstrated for additional cell lines 
including H9 and BGO1v. In addition to X-VIVO 10 and mTeSR1, the surface was found 
compatible with StemPro and NutriStem media. Multipassage hESC data on Synthemax 
surface is summarized in Table 4. 
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For hESC-based therapeutics it is critical to have a defined, scalable culture system for both 
the expansion and differentiation stages of cell production. The picture would not have been 
complete without testing Synthemax surface for hESC differentiation. After passaging cells 
14 times on PAS surface, cells were treated with Activin A and BMP4 as previously 
described (Laflamme et al., 2007) to investigate differentiation into cardiomyocytes. The 
experiment resulted in spontaneously beating cell aggregates expressing the cardiomyocyte-
specific markers, Nkx2.5 and -actinin, and shows that the BSP peptide acrylate surface 
supports both expansion and differentiation of hESC to therapeutic progenitor cells, (see 
Figure 4).  
 
 
      
a)               b) 
Fig. 4. Cardiomyocyte differentiation of H7 hESC on BSP-PAS surface: Immunofluorescent 
staining (a) and flow cytometry analyasis (b) of differentiated cells for cardiomyocyte-
specific markers, Nkx 2.5 shown in red and -actinin shown in green. 
5. Conclusions 
Although a variety of recombinant protein coatings in combination with a defined serum-
free cell culture medium have been shown to provide a good cell culture system for hESCs, 
the limited scalability of most of these systems limits their use for cell therapy applications. 
Peptide acrylate surfaces based on a pure synthetic chemistry approach offer consistency, 
reproducibility, scalability, safety, and eventually lower cost for hESC-derived cell therapy 
applications. 
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